AI Algorithm for Contact Dermatitis
MH
Overseen ByMatthew Hall
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The purpose of this research is to improve how well remote patch allergy testing works and make sure they are easy and practical for people to use from home.
Research Team
MH
Matthew Hall, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
Willing and able to provide informed consent
Exclusion Criteria
I have used steroids, either as a cream or pill, in the last two weeks.
I am on immunosuppressants or have a condition that weakens my immune system.
I don't have a sunburn or rash where the test will be done.
See 3 more
Timeline
Screening
Participants are screened for eligibility to participate in the trial
1-2 weeks
Treatment
Participants will have two allergen patches on their forearms for 48 hours, followed by a photograph for AI and human review
1 week
Follow-up
Participants are monitored for safety and effectiveness after treatment
1 week
Treatment Details
Interventions
- DermAI
Participant Groups
1Treatment groups
Experimental Treatment
Group I: DermAI and Patch Allergen TestingExperimental Treatment2 Interventions
Subjects will have two allergen patches on their forearms for 48 hours and a photograph image of where the patches were placed afterwards for human review and AI predictions of reactions.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Trials
3,427
Recruited
3,221,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.